United States set
Menu Shopping cart $0 Search
Manufactured by BioVendor

Human Growth Hormone Binding Protein (GHBP) ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, Biotin-labelled antibody
  • Other names:GHBP
  • Species:Human
Cat. No. Size Price

RMEE024R 96 wells (1 kit) $644,1
PubMed Product Details
Technical Data


Sandwich ELISA, Biotin-labelled antibody


Serum, Plasma

Sample Requirements

15 µl/well


Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Range

0.006 – 84 ng/mL

Limit of Detection

0.006 ng/mL



  • Is suited for GHBP determination in Serum and Plasma samples
  • Incubation time a total of 3 hours
  • Single Standards with (0.05 – 4ng/mL) recombinant GHBP are provided in the Kit
  • 2 Control Sera are provided for quality control purposes according GLP
  • Microtiter plates are separately breakapart, tests can be adapted to individual requirements

Research topic

Growth hormone and factor-related products


Growth Hormone Binding Protein (GHBP) consists of 238 amino acids and includes four sides for glycosylation and three disulfide bounds. In humans GHBP is formed by receptor shedding of the growth hormone receptor by a metalloprotease (ADAM17). In equilibrium about 50% of circulating growth hormone (GH) is bound to GHBP but only 2% of the circulating GHBP bound a GH molecule with a stoichiometry of 1:1. Only in case of supraphysiological GHBP levels a 2:1 ratio appears. The complex of GH and GHBP has an approximate molecular weight of 80 kDa (GHBP 60 kDa). In an animal model (guniea pig) the complex formation increases half-life from 11-20 minutes up to about 100 minutes and in general binding to GHBP inhibits GH cellular action. GHBP Physiology GHBP concentration is independent of GH pulsatility and does not show a circadian rhythm. GHBP levels are low until 2-6 months of life, increase steeply in the first two years and continue to increase slowly until early adulthood. From the the 4th decade the GHBP serum concentration declines slowly. GHBP correlates positively with the intraabdominal fat mass and is increased in type II diabetics with hyperinsulinaemi. It is not known whether the tight relationship between fat mass and circulating GHBP results from GHBP expression in adipocytes or any other mechanism. From a diagnostic point of view undetectable GHBP levels could point to a GH insensitivity, caused by a deletion in the GH-receptor gene. Further, the IGF-I/GHBP ratio might be an indicator for GH-deficiency in adults, in particular in women. It could also be predictive for GH treatment response. The strong positive relationship with intraabdominal fat mass might be a hint, that GHBP is a possible biomarker for the amount of visceral adipose tissue.

Related Products Docs